OraSure Technologies (NASDAQ: OSUR) reported Q1 EPS of $0.04, $0.04 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $54.13 million versus the consensus estimate of $52.12 million.

GUIDANCE:

OraSure Technologies sees Q2 2024 revenue of $50-55 million, versus the consensus of $53.7 million. Which includes core revenue of $33 to $36 million and InteliSwab revenue of $17 to $19 million. Our Q2 2024 guidance includes approximately $650 thousand of revenue from the Diversigen business that we plan to exit.

For earnings history and earnings-related data on OraSure Technologies (OSUR) click here.